mafosfamide has been researched along with nad in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, RM; Marks, DI | 1 |
| Kohn, FR; Landkamer, GJ; Manthey, CL; Ramsay, NK; Sladek, NE | 1 |
| Sladek, NE; Sreerama, L | 1 |
3 other study(ies) available for mafosfamide and nad
| Article | Year |
|---|---|
DNA damage, poly (ADP-ribosyl)ation and apoptotic cell death as a potential common pathway of cytotoxic drug action.
Topics: Adenosine Triphosphate; Biotransformation; Cell Death; Cell Division; Cyclophosphamide; DNA Damage; Etoposide; Humans; NAD; Poly(ADP-ribose) Polymerases; Time Factors; Tumor Cells, Cultured | 1991 |
Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
Topics: Aldehyde Dehydrogenase; Animals; Colony-Forming Units Assay; Cyanamide; Cyclophosphamide; Disulfiram; Ditiocarb; Drug Resistance; Enzyme Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia L1210; Mice; NAD; Organophosphorus Compounds; Phosphinic Acids; Phosphoramide Mustards | 1987 |
Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
Topics: Adenocarcinoma; Aldehyde Dehydrogenase; Benzaldehydes; Breast Neoplasms; Cell Line; Cyclophosphamide; Drug Resistance; Gastric Mucosa; Gene Expression Regulation, Enzymologic; Humans; Hydrogen-Ion Concentration; Isoenzymes; NAD; NADP; Subcellular Fractions; Temperature | 1993 |